Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Biol Res ; 39(2): 229-36, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16874398

RESUMO

Pre-eclampsia is a hypertensive disorder of pregnancy in which enzymatic antioxidant defenses fail and tissues are injured. This prospective case-control study evaluated whether pre-eclamptic women and their newborns show higher degrees of oxidative stress than normal pregnancies and sought to determine if this stress is related to clinical severity. Forty-four pre-eclamptic and thirty healthy pregnant women attending two hospitals in Valparaíso, Chile, were studied. The following plasmatic variables of antioxidant capacity were evaluated: glutathione peroxidase activity (GPx), total antioxidant capacity measured by oxidation of ABTS substrate (2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid), and superoxide dismutase activity (SOD). malondialdehide (MDA) was measured to evaluate lipoperoxidation. The evaluation was performed at diagnosis of pre-eclampsia, delivery, 30 days and 120 days post delivery. Newborns were studied at delivery through umbilical cord blood samples. Our analysis shows that antioxidant enzyme activity (SOD, GPx, ABTS) was significantly decreased, while lipoperoxidation (MDA) was increased in both pre-eclamptic groups compared to normal pregnant women (p<0.01). Statistically significant difference was found between mild and severe pre-eclamptic groups (p<0.01), for all biochemical markers studied. Therefore, the clinical severity of this pathology is closely related to the degree of oxidative stress.


Assuntos
Peroxidação de Lipídeos , Estresse Oxidativo , Pré-Eclâmpsia/metabolismo , Benzotiazóis/sangue , Benzotiazóis/metabolismo , Biomarcadores/sangue , Estudos de Casos e Controles , Feminino , Sangue Fetal/enzimologia , Glutationa Peroxidase/sangue , Glutationa Peroxidase/metabolismo , Humanos , Recém-Nascido , Pré-Eclâmpsia/diagnóstico , Gravidez , Estudos Prospectivos , Índice de Gravidade de Doença , Ácidos Sulfônicos/sangue , Ácidos Sulfônicos/metabolismo , Superóxido Dismutase/sangue , Superóxido Dismutase/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico
2.
Biol. Res ; 39(2): 229-236, 2006. ilus
Artigo em Inglês | LILACS | ID: lil-432425

RESUMO

Pre-eclampsia is a hypertensive disorder of pregnancy in which enzymatic antioxidant defenses fail and tissues are injured. This prospective case-control study evaluated whether pre-eclamptic women and their newborns show higher degrees of oxidative stress than normal pregnancies and sought to determine if this stress is related to clinical severity. Forty-four pre-eclamptic and thirty healthy pregnant women attending two hospitals in Valparaíso, Chile, were studied. The following plasmatic variables of antioxidant capacity were evaluated: glutathione peroxidase activity (GPx), total antioxidant capacity measured by oxidation of ABTS substrate (2,2'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid), and superoxide dismutase activity (SOD). malondialdehide (MDA) was measured to evaluate lipoperoxidation. The evaluation was performed at diagnosis of pre-eclampsia, delivery, 30 days and 120 days post delivery. Newborns were studied at delivery through umbilical cord blood samples. Our analysis shows that antioxidant enzyme activity (SOD, GPx, ABTS) was significantly decreased, while lipoperoxidation (MDA) was increased in both pre-eclamptic groups compared to normal pregnant women (p<0.01). Statistically significant difference was found between mild and severe pre-eclamptic groups (p<0.01), for all biochemical markers studied. Therefore, the clinical severity of this pathology is closely related to the degree of oxidative stress.


Assuntos
Feminino , Humanos , Recém-Nascido , Gravidez , Peroxidação de Lipídeos , Estresse Oxidativo , Pré-Eclâmpsia/metabolismo , Benzotiazóis/sangue , Benzotiazóis/metabolismo , Biomarcadores/sangue , Estudos de Casos e Controles , Sangue Fetal/enzimologia , Glutationa Peroxidase/sangue , Glutationa Peroxidase/metabolismo , Estudos Prospectivos , Pré-Eclâmpsia/diagnóstico , Índice de Gravidade de Doença , Ácidos Sulfônicos/sangue , Ácidos Sulfônicos/metabolismo , Superóxido Dismutase/sangue , Superóxido Dismutase/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico
3.
Rev Med Chil ; 132(10): 1179-88, 2004 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-15631205

RESUMO

BACKGROUND: Hyper-IgM syndronie (HIGM) is a rare primary immunodeficiency used to describe a heterogeneous group of disorders characterized by recurrey bacterial infrctions, normal or elevated serum IgM levels and low or absent serum IgG, IgA and IgE. AIM: To make definitive diagnosis, detect mutations in carriers and perform genetic counseling in patients with HIGM. PATIENTS AND METHODS: We studied the expression of CD40L, CD40 and made a mutation analysis of the CD40L gene in 3 males of 2 unrelated Chilean families diagnosed as a possible syndrome of hyper-IgM and 3 relatives. RESULTS: We identified a deletion frameshift in the exon 2 (delA225) of the extracellular domain of GD40L gene in one patient and verified the carrier stains of his mother and sister. The other patients showed a low expression of GD40L in activated T cells (65.3% ammd 65.5%) and a normal expressiomi of CD40. No alterations were found in the single strand conformation polymorphism analysis of the CD40L. CONCLUSIONS: These result allowed us to make a definite diagnosis of HIGM1 of a patient, detect female carriers and suggest a HIGM of recessive inheritance with normal CD40 expression in the patients of the second family.


Assuntos
Ligante de CD40/genética , Mutação da Fase de Leitura/genética , Hipergamaglobulinemia/genética , Imunoglobulina M/genética , Peptídeos e Proteínas Associados a Receptores de Fatores de Necrose Tumoral/genética , Ligante de CD40/sangue , Criança , Pré-Escolar , Chile , Feminino , Aconselhamento Genético , Humanos , Hipergamaglobulinemia/diagnóstico , Imunoglobulina M/sangue , Lactente , Masculino , Síndrome , Fator 3 Associado a Receptor de TNF , Peptídeos e Proteínas Associados a Receptores de Fatores de Necrose Tumoral/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...